此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effect of Cordyceps Supplementation Timing on Physiological Responses and Aerobic Adaptation in Athletes (CORD-RECOV)

2026年8月21日 更新者:Bayu Agung Pramono、Surabaya State University

Optimization of Athlete Recovery: Effects of Cordyceps Supplementation Timing on Inflammatory Response, Oxidative Stress, Muscle Damage, and Aerobic Adaptation Following Acute and Chronic Exercise Training

Athletes frequently perform high-intensity exercise to improve physical performance and aerobic capacity. However, such training can induce exercise-induced muscle damage, oxidative stress, and inflammatory responses that may delay recovery and compromise subsequent training adaptations. Optimizing recovery strategies is therefore essential to maintain performance, reduce injury risk, and support long-term athletic development.

Cordyceps is a medicinal mushroom that contains several bioactive compounds, including cordycepin and polysaccharides, which have demonstrated antioxidant, anti-inflammatory, and immunomodulatory properties. Although previous studies have reported beneficial effects of Cordyceps supplementation on exercise performance and physiological function, limited evidence exists regarding the optimal timing of supplementation relative to exercise.

This study aims to investigate the effects of different Cordyceps supplementation timing strategies on physiological responses and aerobic adaptation following acute and chronic exercise training. Participants will be assigned to receive Cordyceps supplementation before exercise, after exercise, or placebo. The study will evaluate biomarkers of inflammation (IL-6), oxidative stress (MDA), muscle damage (CK), aerobic capacity (VO2max), and neuromuscular performance assessed using countermovement jump (CMJ) testing.

The findings of this study are expected to provide evidence-based recommendations regarding nutritional recovery strategies and supplementation timing to optimize recovery and training adaptation in athletes and physically active individuals.

研究概览

详细说明

Background

Recovery is a fundamental component of the training process because physiological adaptation occurs not only during exercise but also during the recovery period following exercise-induced stress. High-intensity exercise is widely used to improve athletic performance and aerobic capacity; however, it is also associated with increased physiological stress, including exercise-induced muscle damage (EIMD), oxidative stress, and inflammatory responses. Excessive accumulation of these responses may impair recovery, reduce training quality, increase injury risk, and contribute to non-functional overreaching or overtraining.

Exercise-induced physiological stress is commonly characterized by elevations in inflammatory biomarkers such as interleukin-6 (IL-6), muscle damage markers such as creatine kinase (CK), and oxidative stress markers such as malondialdehyde (MDA). Conversely, appropriate recovery interventions may facilitate restoration of physiological homeostasis and support positive training adaptations, including improvements in aerobic capacity.

Cordyceps is a medicinal fungus that contains several biologically active compounds, including cordycepin, polysaccharides, nucleosides, sterols, and phenolic compounds. Experimental and clinical studies have demonstrated antioxidant, anti-inflammatory, and immunomodulatory properties of Cordyceps. These mechanisms suggest that Cordyceps supplementation may help attenuate exercise-induced physiological stress while supporting recovery and adaptation processes.

Despite increasing interest in Cordyceps supplementation among athletes, evidence regarding the influence of supplementation timing remains limited. Most previous studies have focused primarily on supplementation efficacy without specifically evaluating whether administration before exercise or after exercise produces differential physiological effects. Understanding the role of supplementation timing may contribute to the development of more effective recovery strategies in sports science.

Objectives

The primary objective of this study is to evaluate the effects of Cordyceps supplementation timing on exercise-induced physiological responses and aerobic adaptation following acute and chronic exercise training.

Specific objectives include:

  1. To compare the effects of pre-exercise and post-exercise Cordyceps supplementation on inflammatory response, muscle damage, and oxidative stress following acute exercise.
  2. To compare the effects of pre-exercise and post-exercise Cordyceps supplementation on inflammatory response, muscle damage, oxidative stress, and aerobic capacity following chronic exercise training.
  3. To compare physiological responses among pre-exercise supplementation, post-exercise supplementation, and placebo groups.
  4. To evaluate the interaction between supplementation timing and exercise exposure on selected physiological biomarkers.
  5. To investigate the relationship between changes in oxidative stress, muscle damage, and aerobic adaptation.

Study Rationale

The scientific rationale of this study is based on the hypothesis that the timing of nutrient delivery may influence physiological responses to exercise. Supplementation administered before exercise may enhance physiological preparedness and reduce exercise-induced stress, whereas supplementation administered after exercise may facilitate recovery and tissue regeneration processes. Identifying the optimal timing strategy may improve recovery efficiency and maximize training adaptation.

Study Outcomes

The study will evaluate biomarkers associated with inflammation, oxidative stress, and muscle damage, including IL-6, MDA, and CK. Aerobic adaptation will be assessed through maximal oxygen uptake (VO2max). In addition to biochemical markers and aerobic capacity, neuromuscular performance will be assessed using countermovement jump (CMJ) testing performed on a validated VALD system. CMJ variables will be used to evaluate lower-body power output and neuromuscular recovery status following acute and chronic exercise exposure.

Potential Significance

This study is expected to generate novel evidence regarding the role of Cordyceps supplementation timing in athletic recovery and adaptation. The findings may support the development of evidence-based nutritional strategies for athletes, coaches, sports scientists, and healthcare professionals. Furthermore, the study may contribute to a better understanding of the relationship between oxidative stress, inflammation, muscle damage, and aerobic adaptation during exercise training.

研究类型

介入性

注册 (实际的)

30

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Jawa Timur - East Java
      • Surabaya、Jawa Timur - East Java、印度尼西亚、60213
        • Faculty of Sport and Health Sciences

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人

接受健康志愿者

是的

描述

Inclusion Criteria:

  • Male participants aged 19-21 years.
  • Students enrolled in the Sport Coaching Education Program (Pendidikan Kepelatihan Olahraga).
  • Apparently healthy and free from known cardiovascular, metabolic, respiratory, neuromuscular, or musculoskeletal disorders that could affect participation in exercise training.
  • Regularly participate in physical exercise at least three times per week during the previous three months.
  • Willing to comply with all study procedures, exercise protocols, supplementation schedules, and assessment sessions.
  • Provide written informed consent before participation.

Exclusion Criteria:

  • Current injury or musculoskeletal condition that limits participation in exercise training.
  • History of cardiovascular disease, uncontrolled hypertension, diabetes mellitus, respiratory disease, or other medical conditions that may increase exercise-related risk.
  • Use of antioxidant supplements, herbal supplements, ergogenic aids, or anti-inflammatory medications within four weeks prior to study enrollment.
  • Known allergy or hypersensitivity to Cordyceps or any component of the study supplements.
  • Smoking or excessive alcohol consumption during the study period.
  • Failure to comply with supplementation or exercise protocols.
  • Participation in another research study during the study period.
  • Participants presenting acute infection, fever, or inflammatory conditions within two weeks prior to baseline assessment.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
实验性的:Pre-Exercise Cordyceps
Participants receive Cordyceps supplementation twice prior to exercise sessions, with administration occurring approximately 11 hours and 1 hour before exercise. This intervention is designed to evaluate the effects of pre-exercise supplementation timing on inflammatory response, oxidative stress, muscle damage, neuromuscular performance, and aerobic adaptation following acute and chronic exercise training.
Participants in the pre-exercise group received 200 mg of a 10:1 Cordyceps sinensis CS-4 extract per administration (equivalent to 2,000 mg of raw Cordyceps material), with two capsules administered approximately 11 hours and 1 hour before each exercise session. Supplementation was provided three times per week for 4 weeks. The intervention is designed to evaluate the effects of pre-exercise supplementation timing on inflammatory response (IL-6), oxidative stress (MDA), muscle damage (CK), countermovement jump (CMJ) performance, and aerobic adaptation (VO2max).
其他名称:
  • cordyceps
实验性的:Post-Exercise Cordyceps
Participants receive Cordyceps supplementation immediately after completion of each exercise session. This intervention is designed to evaluate the effects of post-exercise supplementation timing on physiological recovery, neuromuscular performance, and aerobic adaptation following acute and chronic exercise training.
Participants in the post-exercise group received 200 mg of a 10:1 Cordyceps sinensis CS-4 extract (equivalent to 2,000 mg of raw Cordyceps material; two capsules) immediately after each exercise session, three times per week for 4 weeks. The intervention is designed to evaluate the effects of post-exercise supplementation timing on inflammatory response (IL-6), oxidative stress (MDA), muscle damage (CK), countermovement jump (CMJ) performance, and aerobic adaptation (VO2max).
其他名称:
  • Cordyceps
安慰剂比较:Placebo
Participants receive placebo capsules matched in appearance and administration schedule to the Cordyceps supplementation groups. The placebo group serves as the control condition for comparison of physiological and performance outcomes.
Participants received two placebo capsules immediately after each exercise session, three times per week for 4 weeks. The placebo capsules contained the same excipient base without Cordyceps sinensis extract and were identical to the active capsules in appearance, size, packaging, and administration procedure to maintain blinding. and serves as the control condition for comparison of physiological and performance outcomes.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Interleukin-6 (IL-6)
大体时间:Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.
Serum interleukin-6 (IL-6) concentration measured as a biomarker of exercise-induced inflammatory response following acute and chronic exercise training.
Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.
Creatine Kinase (CK)
大体时间:Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.
Serum creatine kinase (CK) concentration measured as a biomarker of exercise-induced muscle damage following acute and chronic exercise training.
Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.
Malondialdehyde (MDA)
大体时间:Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.
Serum malondialdehyde (MDA) concentration measured as a biomarker of oxidative stress following acute and chronic exercise training.
Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.
Maximal Oxygen Uptake (VO2max)
大体时间:Baseline and after 4 weeks of chronic exercise training.
Maximal oxygen uptake (VO2max) assessed as an indicator of aerobic capacity and chronic training adaptation.
Baseline and after 4 weeks of chronic exercise training.

次要结果测量

结果测量
措施说明
大体时间
Countermovement Jump (CMJ) Performance
大体时间:Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.
Countermovement jump performance assessed using the VALD ForceDecks system as an indicator of neuromuscular function and recovery following acute and chronic exercise training.
Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 学习椅:Nining W Kusnanik, Dr.、Surabaya State University
  • 研究主任:Agus Hariyanto, Dr.、Surabaya State University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

有用的网址

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年6月9日

初级完成 (实际的)

2026年8月1日

研究完成 (实际的)

2026年8月10日

研究注册日期

首次提交

2026年6月17日

首先提交符合 QC 标准的

2026年6月17日

首次发布 (实际的)

2026年6月24日

研究记录更新

最后更新发布 (实际的)

2026年8月25日

上次提交的符合 QC 标准的更新

2026年8月21日

最后验证

2026年8月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • B/41816/UN38.16/TU.00.02/202
  • UNESA-S3IK-2026-01 (其他标识符:Universitas Negeri Surabaya)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

Individual participant data (IPD) that underlie the results reported in publications, after de-identification, will be made available to qualified researchers upon reasonable request. Data sharing will be permitted for scientifically sound research purposes following publication of the primary study results. Requests for access to the data will be reviewed by the principal investigator and must comply with institutional and ethical requirements. Supporting documents, including the study protocol and statistical analysis plan, may also be made available upon request.

IPD 共享时间框架

Individual participant data (IPD), study protocol, and statistical analysis plan will be available beginning after publication of the primary and secondary study results and will remain available for 5 years thereafter.

IPD 共享访问标准

De-identified individual participant data (IPD), study protocol, and statistical analysis plan will be available to qualified researchers upon reasonable request. Access requests must include a scientifically sound research proposal and the intended use of the data. Requests will be reviewed by the principal investigator to ensure compliance with ethical, legal, and institutional requirements. Approved researchers will be granted access to the relevant data and supporting documents through direct communication with the principal investigator and, when appropriate, under a data-sharing agreement.

IPD 共享支持信息类型

  • 研究方案
  • 树液

研究数据/文件

  1. 研究协议
    信息标识符:PROTOCOL-2026
    信息评论:The study protocol will be available upon reasonable request to the principal investigator following publication of the primary and secondary study results.
  2. 统计分析计划
    信息标识符:SAP-2026
    信息评论:The statistical analysis plan will be available upon reasonable request to qualified researchers following publication of the primary and secondary study results

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅